⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for nimotuzumab

Every month we try and update this database with for nimotuzumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPCNCT03557112
Nasopharyngeal ...
Nimotuzumab
Cisplatin
18 Years - 70 YearsGuiyang Medical University
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine NeoplasmsNCT05316480
Pancreatic Neur...
Nimotuzumab
18 Years - 80 YearsFudan University
Nimotuzumab With Radiotherapy in the Treatment of Anal Canal CancersNCT01382745
Squamous Cell C...
Nimotuzumab
Intensity Modul...
18 Years - Sir Mortimer B. Davis - Jewish General Hospital
Nimotuzumab in Combination With Radiotherapy for Esophageal CancerNCT02591784
Esophageal
Nimotuzumab
Radiotherapy
18 Years - 75 YearsBiotech Pharmaceutical Co., Ltd.
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical TrialNCT01463605
Esophageal Canc...
Nimotuzumab
70 Years - ChineseAMS
Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic CancerNCT06389760
Pancreatic Canc...
Nimotuzumab
mFOLFIRINOX
18 Years - 70 YearsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nimotuzumab in Adults With Glioblastoma MultiformaNCT00753246
Adults With Gli...
nimotuzumab
18 Years - 70 YearsOncoscience AG
Pharmacokinetics Study of Nimotuzumab in Patients With Solid TumorsNCT02395068
Solid Tumors
Nimotuzumab
irinotecan
18 Years - 70 YearsBiotech Pharmaceutical Co., Ltd.
Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in ChildrenNCT04532229
Diffuse Intrins...
Nimotuzumab+CRT...
3 Years - 15 YearsBiotech Pharmaceutical Co., Ltd.
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal CarcinomaNCT02858206
Esophageal Neop...
IMRT simultaneo...
Nimotuzumab
Paclitaxel
Nedaplatin
Esophagectomy
18 Years - 69 YearsChineseAMS
Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical CancerNCT02039791
Cervical Cancer
Nimotuzumab
Carboplatin
Paclitaxel
18 Years - 70 YearsBiotech Pharmaceutical Co., Ltd.
Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After EsophagectomyNCT01402180
Esophageal Squa...
Nimotuzumab
Radiation thera...
radiation thera...
chemotherapy
chemotherapy
18 Years - 75 YearsFudan University
Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell CarcinomaNCT02272699
Esophageal Squa...
Nimotuzumab
Paclitaxel
Cisplatin
Radiation
Surgery
18 Years - 65 YearsPeking University
Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell CarcinomaNCT02272699
Esophageal Squa...
Nimotuzumab
Paclitaxel
Cisplatin
Radiation
Surgery
18 Years - 65 YearsPeking University
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile CancerNCT04475016
Penile Cancer
Albumin-Bound P...
Ifosfamide
Cisplatin
Nimotuzumab
Triprilimab
18 Years - 75 YearsSun Yat-sen University
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic CancerNCT06429904
Locally Advance...
Nimotuzumab+ NA...
18 Years - 75 YearsPeking Union Medical College Hospital
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric AdenocarcinomaNCT02370849
Stomach Neoplas...
nimotuzumab
cisplatin
S-1
18 Years - ChineseAMS
Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal CancerNCT01899118
Locally Advance...
Preoperative ir...
Nimotuzumab
Oxaliplatin
Capecitabine
18 Years - 75 YearsZhejiang Cancer Hospital
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic CancerNCT06429904
Locally Advance...
Nimotuzumab+ NA...
18 Years - 75 YearsPeking Union Medical College Hospital
Nimotuzumab for Recurrent Nasopharyngeal CarcinomaNCT03666221
Recurrent Nasop...
Nimotuzumab
18 Years - 70 YearsFujian Cancer Hospital
Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.NCT01993784
Esophageal Squa...
nimotuzumab
18 Years - 75 YearsPeking University
Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After SurgeryNCT05024019
Head and Neck S...
Nimotuzumab
18 Years - Eye & ENT Hospital of Fudan University
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer SurgeryNCT04459065
Lung Cancer
IRDye800CW-nimo...
18 Years - 80 YearsUniversity of Saskatchewan
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx CancerNCT01516996
Oropharyngeal C...
Hypopharyngeal ...
docetaxel and c...
IMRT
Nimotuzumab
18 Years - 70 YearsThe Second People's Hospital of Sichuan
Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric CancerNCT01180166
Gastric Cancer
Concurrent Chem...
nimotuzumab
18 Years - 75 YearsChineseAMS
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK CellsNCT03554889
Advanced Cancer
ADCC
NK Cell Mediate...
Nimotuzumab
Adaptive Transf...
NK Cell adaptiv...
Nimotuzumab
18 Years - 75 YearsHangzhou Cancer Hospital
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerNCT00983047
Advanced Non-Sm...
Nimotuzumab and...
18 Years - 75 YearsBiotech Pharmaceutical Co., Ltd.
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell CancerNCT00702481
Head and Neck C...
Nimotuzumab
Cisplatin
Radiation
21 Years - 70 YearsNational Cancer Centre, Singapore
Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung CancerNCT00985998
Non-small Cell ...
Nimotuzumab and...
18 Years - 65 YearsBiotech Pharmaceutical Co., Ltd.
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic CancerNCT06409429
Pancreatic Canc...
Nimotuzumab
GX
Placebo
18 Years - 75 YearsTianjin Medical University Cancer Institute and Hospital
Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPCNCT02012062
Nasopharyngeal ...
TPF neoadjuvant...
Concurrent chem...
Concurrent nimo...
Radical radioth...
18 Years - 70 YearsFudan University
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old AgeNCT06048913
Esophageal Carc...
Nimotuzumab
Tigio
Concurrent radi...
70 Years - The First Affiliated Hospital with Nanjing Medical University
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx CancerNCT01516996
Oropharyngeal C...
Hypopharyngeal ...
docetaxel and c...
IMRT
Nimotuzumab
18 Years - 70 YearsThe Second People's Hospital of Sichuan
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer PatientsNCT06429839
Esophageal Canc...
Nimotuzumab
Chemoradiothera...
Chemotherapy
Immunotherapy
Nimotuzumab wit...
18 Years - 80 YearsCancer Institute and Hospital, Chinese Academy of Medical Sciences
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric AdenocarcinomaNCT02370849
Stomach Neoplas...
nimotuzumab
cisplatin
S-1
18 Years - ChineseAMS
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile CancerNCT04475016
Penile Cancer
Albumin-Bound P...
Ifosfamide
Cisplatin
Nimotuzumab
Triprilimab
18 Years - 75 YearsSun Yat-sen University
Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical CancerNCT01938105
Locally Advance...
Nimotuzumab+che...
18 Years - 75 YearsPeople's Hospital of Guangxi
Nimotuzumab in Children With Intrinsic Pontine GliomaNCT00561691
Diffuse Instrin...
nimotuzumab
3 Years - 20 YearsOncoscience AG
Study of Nimotuzumab and Irinotecan in Metastatic Colorectal CancerNCT00493857
Colorectal Canc...
Nimotuzumab Hum...
Nimotuzumab
18 Years - YM BioSciences
Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPCNCT02012062
Nasopharyngeal ...
TPF neoadjuvant...
Concurrent chem...
Concurrent nimo...
Radical radioth...
18 Years - 70 YearsFudan University
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell CarcinomaNCT06410651
Esophageal Canc...
Nimotuzumab
Chemoradiothera...
Chemotherapy
Immunotherapy
Nimotuzumab wit...
18 Years - 80 YearsCancer Institute and Hospital, Chinese Academy of Medical Sciences
Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell CarcinomaNCT04976478
Cervical Squamo...
Nimotuzumab
EBRT combined w...
65 Years - Peking University Third Hospital
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction CancerNCT01813253
Gastric Cancer
Gastroesophagea...
Irinotecan
Nimotuzumab
20 Years - Kuhnil Pharmaceutical Co., Ltd.
Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal CarcinomaNCT03915132
Nasopharyngeal ...
Nimotuzumab
VMAT
70 Years - ChineseAMS
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK CellsNCT03554889
Advanced Cancer
ADCC
NK Cell Mediate...
Nimotuzumab
Adaptive Transf...
NK Cell adaptiv...
Nimotuzumab
18 Years - 75 YearsHangzhou Cancer Hospital
Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After SurgeryNCT05024019
Head and Neck S...
Nimotuzumab
18 Years - Eye & ENT Hospital of Fudan University
Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell CarcinomaNCT02611700
Esophageal Squa...
Nimotuzumab
Paclitaxel
Cisplatin
Placebo
18 Years - Biotech Pharmaceutical Co., Ltd.
A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal CancerNCT01249352
Esophageal Canc...
Adenocarcinoma
Nimotuzumab
Cisplatin
Fluorouracil
Radiotherapy
18 Years - Eurofarma Laboratorios S.A.
Nimotuzumab Plus AG in Pancreatic Cancer With Liver MetastasisNCT06405685
Pancreatic Canc...
Nimotuzumab
AG
18 Years - 75 YearsTianjin Medical University Cancer Institute and Hospital
Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell CarcinomaNCT01688700
Esophageal Squa...
Nimotuzumab com...
18 Years - 70 YearsZhejiang Cancer Hospital
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaNCT03025958
Nasopharyngeal ...
Nimotuzumab
Radiation
65 Years - Zhejiang Cancer Hospital
Nimotuzumab and Radiotherapy in Pediatric Patients With GliomaNCT01145170
Diffuse Intrins...
Radiotherapy
Nimotuzumab
3 Years - 18 YearsEurofarma Laboratorios S.A.
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic CancerNCT06429904
Locally Advance...
Nimotuzumab+ NA...
18 Years - 75 YearsPeking Union Medical College Hospital
Nimotuzumab in Adults With Pancreatic CancerNCT00561990
Pancreatic Canc...
Nimotuzumab
18 Years - 100 YearsOncoscience AG
Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in ChildrenNCT02672241
Childhood Brain...
Nimotuzumab
Temozolomide
3 Years - 12 YearsXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical CancerNCT02705612
Cervical Cancer
Cisplatin
External Beam R...
Internal Radiat...
nimotuzumab
18 Years - 70 YearsAir Force Military Medical University, China
Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment FailureNCT06413017
HCC
Nimotuzumab
ICIs(Immune che...
17 Years - 79 YearsTianjin Medical University Cancer Institute and Hospital
Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC PatientsNCT01393080
Non-small Cell ...
Nimotuzumab and...
TP regimen
18 Years - 70 YearsTianjin Medical University Cancer Institute and Hospital
Neoadjuvant Chemoradiotherapy Combined With Camrelizumab and Nimotuzumab for Esophageal Squamous Cell CarcinomaNCT05355168
Toxicity, Drug
neoadjuvant che...
18 Years - 75 YearsAnhui Provincial Hospital
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II StudyNCT06404840
Pancreatic Canc...
nimotuzumab
AG chemotherapy
18 Years - 75 YearsTianjin Medical University Cancer Institute and Hospital
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell CancerNCT01336049
Esophageal Squa...
Nimotuzumab
18 Years - 75 YearsPeking University
Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral GlioblastomaNCT03388372
Glioblastoma
Nimotuzumab
Temozolomide
Radiotherapy
18 Years - 75 YearsBiotech Pharmaceutical Co., Ltd.
Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)NCT00910117
Head and Neck C...
nimotuzumab
PF regimen (cis...
18 Years - 70 YearsFudan University
Chemoradiotherapy in Esophageal or Esophagogastric Junction CancerNCT04821778
Esophagus Cance...
Esophagogastric...
Chemoradiation
Targeted Therap...
Immunotherapy
Chemotherapy Ef...
Radiotherapy
Platinum based ...
Paclitaxel base...
Immunotherapy
5-FU Analog bas...
Nimotuzumab
18 Years - ChineseAMS
Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous CarcinomaNCT04664244
Recurrent Cervi...
Radiotherapy
Epidermal Growt...
Nimotuzumab
Objective Respo...
Progression-fre...
Overall Surviva...
Combination of ...
18 Years - Peking Union Medical College Hospital
Nimotuzumab for Recurrent Nasopharyngeal CarcinomaNCT03666221
Recurrent Nasop...
Nimotuzumab
18 Years - 70 YearsFujian Cancer Hospital
Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaNCT03400592
Stomach Neoplas...
Irinotecan
nimotuzumab
18 Years - 80 YearsPeking University
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung CancerNCT00369447
Non-small-cell ...
External radiot...
nimotuzumab
18 Years - YM BioSciences
A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell CarcinomaNCT04367909
Oral Squamous C...
Nimotuzumab
Docetaxel
Carboplatin
18 Years - 75 YearsChina Three Gorges University, Yichang, China
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell CancerNCT01336049
Esophageal Squa...
Nimotuzumab
18 Years - 75 YearsPeking University
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain MetastasesNCT00872482
Metastatic Non-...
nimotuzumab
18 Years - YM BioSciences
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal CarcinomaNCT02858206
Esophageal Neop...
IMRT simultaneo...
Nimotuzumab
Paclitaxel
Nedaplatin
Esophagectomy
18 Years - 69 YearsChineseAMS
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung CarcinomaNCT02428764
Lung Cancer
Nimotuzumab
Gemcitabine
Carboplatin
Surgery
18 Years - 75 YearsSun Yat-sen University
A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic CancerNCT06363084
Resectable Panc...
Nimotuzumab
18 Years - Ruijin Hospital
Nimotuzumab and Radiotherapy in Pediatric Patients With GliomaNCT01145170
Diffuse Intrins...
Radiotherapy
Nimotuzumab
3 Years - 18 YearsEurofarma Laboratorios S.A.
A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHNNCT04949503
Locally Advance...
nimotuzumab
18 Years - Biotech Pharmaceutical Co., Ltd.
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell CancerNCT00702481
Head and Neck C...
Nimotuzumab
Cisplatin
Radiation
21 Years - 70 YearsNational Cancer Centre, Singapore
Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC PatientsNCT01393080
Non-small Cell ...
Nimotuzumab and...
TP regimen
18 Years - 70 YearsTianjin Medical University Cancer Institute and Hospital
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic CancerNCT06429904
Locally Advance...
Nimotuzumab+ NA...
18 Years - 75 YearsPeking Union Medical College Hospital
Nimotuzumab in Children With Intrinsic Pontine GliomaNCT00561691
Diffuse Instrin...
nimotuzumab
3 Years - 20 YearsOncoscience AG
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: